Patents by Inventor Adam YALIN

Adam YALIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240239886
    Abstract: Provided are antibodies to TREM2 and Gpnmb. Also provided are compositions comprising the antibodies and methods of using same.
    Type: Application
    Filed: February 5, 2024
    Publication date: July 18, 2024
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Ido AMIT, Chamutal BORNSTEIN-OVITS, Adam YALIN, Adi MOSHE, Oren BARBOY, Assaf WEINER, Yonatan KATZENELENBOGEN, Diego JAITIN, Fadi SHEBAN
  • Publication number: 20220372145
    Abstract: A method of reducing the immune suppressor activity of myeloid cells is disclosed. The method comprises contacting myeloid cells with an effective amount of an agent which specifically reduces the amount and/or activity of myeloid cells expressing both Triggering Receptor Expressed On Myeloid Cells 2 (Trem2) and Transmembrane glycoprotein NMB (Gpnmb). The method can be used for treating cancer. Antibodies and bi-specific antibodies are also disclosed.
    Type: Application
    Filed: July 29, 2022
    Publication date: November 24, 2022
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Ido AMIT, Assaf WEINER, Yonatan KATZENELENBOGEN, Adam YALIN, Fadi SHEBAN